Pluristem Therapeutics Inc.
NASDAQ: PSTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yaky Yanay
- Employees
- 153
- Headquarters
- Haifa, Israel
- IPO year
- 2007
- Market cap
- $40.8M
- Website
- https://www.pluristem.com
Loading PSTI…
Loading profile data…Frequently asked questions about PSTI
What does Pluristem Therapeutics Inc. (PSTI) do?
Pluristem Therapeutics Inc., an Israeli biotechnology firm founded in 2001 and based in Haifa, specializes in the discovery, advancement, clinical assessment, and production of innovative cell-based therapeutic products. The company's primary focus is on addressing a spectrum of severe medical conditions, including those related to reduced blood...
Where does PSTI trade?
Pluristem Therapeutics Inc. (PSTI) trades on the NASDAQ Global Market.
What sector is PSTI in?
Pluristem Therapeutics Inc. (PSTI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pluristem Therapeutics Inc.?
Yaky Yanay is the chief executive officer of Pluristem Therapeutics Inc. (PSTI).
Where is Pluristem Therapeutics Inc. headquartered?
Pluristem Therapeutics Inc. is headquartered in Israel.
Does PSTI pay a dividend?
Pluristem Therapeutics Inc. (PSTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSTI go public?
Pluristem Therapeutics Inc. (PSTI) completed its initial public offering in 2007.